AHCY p.Arg285Trp
c.853C>T · rs116846245 · VCV715465
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1425 | likely benign |
|---|---|---|
| REVEL | 0.429 | indeterminate |
| SaProt | LLR -11.58 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.4 | GERP -1.3, phastCons 1 |
| Regional constraint | o/e 0.76 | unconstrained · MANE · 22 kb · p 2.6e-09 · regional, not allelic |
| Overall | ||
| CADD | 22.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 1.35% | 74 |
| African / African-Americangrpmax | 0.376% | 266 |
| Remaining individualsnot grpmax-eligible | 0.12% | 833 |
| South Asian | 0.0165% | 6,072 |
| East Asian | 0.0134% | 7,480 |
| Admixed American | 0.0133% | 7,502 |
| European (non-Finnish) | 0.00441% | 22,693 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AHCY
- Protein
- p.Arg285Trp
- Coding
- c.853C>T
- MANE Select
- NM_000687
- dbSNP
- rs116846245
- Type
- single nucleotide variant
- Location
- chr20:34290552 (GRCh38)
- Gene constraint
- LOEUF 0.727 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 98.21 · 10 PDB
- Residue 285
- a UniProt-annotated variant site (in hmahchd; loss of adenosylhomocysteinase activity); an α-helix
Disease context
hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor S-adenosylhomocysteine hydrolase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Similar variants
- AHCY p.Arg285Gln Uncertain significance ★ ⚠ same residue
- AHCY p.Arg49Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
- AHCY p.Asp86Gly Pathogenic/Likely pathogenic ★★ same condition
- AHCY p.Tyr143Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
- AHCY c.-63A>G Uncertain significance ★★ same condition
- AHCY c.*181C>T Uncertain significance ★★ same condition
- AHCY p.Ala15Thr Uncertain significance ★★ ⚠ same condition
- AHCY p.Ala16Pro Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ahcy-p-arg285trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown